✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹786 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
786 Cr
PE
PE
-
Prom Holding
Prom Holding
67.20 %
ROE (%)
ROE (%)
7.36
ROCE (%)
ROCE (%)
7.27
Div Yield (%)
Div Yield (%)
-
Sales
Sales
340 Cr
OPM (%)
OPM (%)
0.80 %
Debt to Equity
Debt to Equity
0.80
About
Bharat Parenterals limited is dealing in Manufacturing of Pharmaceutical Formulations. The com… Read more
Low
802
52W Range
High
1870
  • Bharat Parenterals
  • Sakar Healthcare
  • Shivalik Rasayan
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

10 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Alembic Pharmaceuticals Ltd.
    • Sun Pharmaceutical Industries Ltd.
    FAQs on Bharat Parenterals Ltd. Business

    Bharat Parenterals Limited specializes in manufacturing pharmaceutical formulations for domestic and international markets, aiming to become a leading company by providing high-quality products meeting customer and regulatory standards.

    Bharat Parenterals major competitors are Sakar Healthcare, Shivalik Rasayan, Kilitch Drugs(India), Ind-Swift Lab., Wanbury, Venus Remedies, Jenburkt Pharma.
    Market Cap of Bharat Parenterals is ₹786 Crs.
    While the median market cap of its peers are ₹686 Crs.

    Bharat Parenterals seems to be less financially stable compared to its competitors.
    Altman Z score of Bharat Parenterals is 2.78 and is ranked 8 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Jun Sep Dec
    Investor Presentation Mar Dec
    Conference Call Mar
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material